Medicenna Therapeutics Market Cap

Medicenna Therapeutics has a market cap or net worth of $46.65 million as of February 12, 2026. Its market cap has decreased by -34.01% in one year.

Market Cap

46.65M

Enterprise Value

35.17M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.56

Market Cap Chart

Since March 8, 2017, Medicenna Therapeutics's market cap has decreased from 48.70M to 46.65M, a decrease of -4.20%. That is a compound annual growth rate of -0.48%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	46.65M	-16.65%
Dec 31, 2025	55.97M	-37.60%
Dec 31, 2024	89.69M	305.00%
Dec 29, 2023	22.15M	-32.75%
Dec 30, 2022	32.93M	-63.24%
Dec 31, 2021	89.58M	-62.05%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Mar 8, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BioStem Technologies	105.50M
Nuo Therapeutics	76.77M
VitaSpring Biomedical	51.78M
Vicapsys Life Sciences	48.56M
Arch Biopartners	43.72M
ZIVO Bioscience	40.17M
Cell Source	38.23M
Harvard Apparatus Regenerative Technology	31.12M

Market Cap Rankings